Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Atrial Fibrillation and Non-cardiovascular Diseases: A Systematic Review
Cátia Ferreira, Rui Providência, Maria João Ferreira, et al.
Arquivos Brasileiros de Cardiologia (2015)
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort
Janice L. Atkins, Jane Masoli, João Delgado, et al.
The Journals of Gerontology Series A (2020) Vol. 75, Iss. 11, pp. 2224-2230
Open Access | Times Cited: 438
A smart nanosensor for the detection of human immunodeficiency virus and associated cardiovascular and arthritis diseases using functionalized graphene-based transistors
Saurav Islam, Shruti Shukla, Vivek K. Bajpai, et al.
Biosensors and Bioelectronics (2018) Vol. 126, pp. 792-799
Closed Access | Times Cited: 131
Management of atrial fibrillation: two decades of progress — a scientific statement from the European Cardiac Arrhythmia Society
Samuel Lévy, Gerhard Steinbeck, Luca Santini, et al.
Journal of Interventional Cardiac Electrophysiology (2022) Vol. 65, Iss. 1, pp. 287-326
Closed Access | Times Cited: 38
Preexisting Comorbidities Predicting Severe Covid-19 in Older Adults in the UK Biobank Community Cohort
Janice L. Atkins, Jane Masoli, João Delgado, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 58
Anticancer Therapy-Induced Atrial Fibrillation: Electrophysiology and Related Mechanisms
Xinyu Yang, Xinye Li, Mengchen Yuan, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 57
Wearable sensors: can they benefit patients with chronic kidney disease?
Fokko P. Wieringa, Natascha Juliana Hendrika Broers, Jeroen P. Kooman, et al.
Expert Review of Medical Devices (2017) Vol. 14, Iss. 7, pp. 505-519
Open Access | Times Cited: 50
Greater variability in lipid measurements associated with cardiovascular disease and mortality: A 10‐year diabetes cohort study
Eric Yuk Fai Wan, Esther Yee Tak Yu, Weng Yee Chin, et al.
Diabetes Obesity and Metabolism (2020) Vol. 22, Iss. 10, pp. 1777-1788
Open Access | Times Cited: 42
4S‐AF scheme and ABC pathway guided management improves outcomes in atrial fibrillation patients
Yutao Guo, Jacopo Francesco Imberti, Agnieszka Kotalczyk, et al.
European Journal of Clinical Investigation (2022) Vol. 52, Iss. 6
Open Access | Times Cited: 25
The Impact of Risk Factors and Comorbidities on The Incidence of Atrial Fibrillation
Nabil Naser, Mirza Dilić, Azra Durak, et al.
Materia Socio Medica (2017) Vol. 29, Iss. 4, pp. 231-231
Open Access | Times Cited: 46
Cancer, atrial fibrillation, and stroke
Tess Fitzpatrick, Marc Carrier, Grégoire Le Gal
Thrombosis Research (2017) Vol. 155, pp. 101-105
Closed Access | Times Cited: 42
KCa3.1 upregulation mediated by Ang II-induced JNK/AP-1 activation contributes to atrial fibrosis
Dongmei Zhang, Guangyao Li, Xuwen Liu, et al.
Cellular Signalling (2025), pp. 111731-111731
Closed Access
Current practice in the management of new-onset atrial fibrillation in critically ill patients: a UK-wide survey
Chung Shen Chean, Daniel F. McAuley, Anthony Gordon, et al.
PeerJ (2017) Vol. 5, pp. e3716-e3716
Open Access | Times Cited: 38
Cancer increases the risk of atrial fibrillation during long-term follow-up (OPERA study)
Helena Kattelus, Y. Antero Kesäniemi, Heikki V. Huikuri, et al.
PLoS ONE (2018) Vol. 13, Iss. 10, pp. e0205454-e0205454
Open Access | Times Cited: 35
Pathophysiology of cancer therapy-provoked atrial fibrillation
Wanli Cheng, Yu‐Hsun Kao, Shih-Ann Chen, et al.
International Journal of Cardiology (2016) Vol. 219, pp. 186-194
Closed Access | Times Cited: 32
Atrial fibrillation and cancer; understanding the mysterious relationship through a systematic review
Noman Lateef, Vikas Kapoor, Muhammad Junaid Ahsan, et al.
Journal of Community Hospital Internal Medicine Perspectives (2020) Vol. 10, Iss. 2, pp. 127-132
Open Access | Times Cited: 28
Long-Term Sports Practice and Atrial Fibrillation: An Updated Review of a Complex Relationship
Mattia Petrungaro, Liuba Fusco, Elena Cavarretta, et al.
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 5, pp. 218-218
Open Access | Times Cited: 10
Causes of Death in Different Subtypes of Ischemic and Hemorrhagic Stroke
Chi‐Hung Liu, Jr‐Rung Lin, Chia‐Wei Liou, et al.
Angiology (2017) Vol. 69, Iss. 7, pp. 582-590
Closed Access | Times Cited: 22
Incidence, Management, Prevention and Outcome of Post-Operative Atrial Fibrillation in Thoracic Surgical Oncology
Iacopo Fabiani, Alessandro Colombo, Giulia Bacchiani, et al.
Journal of Clinical Medicine (2019) Vol. 9, Iss. 1, pp. 37-37
Open Access | Times Cited: 19
Association between atrial fibrillation and Helicobacter pylori
Cecilia Tetta, Amalia Ioanna Moula, Francesco Matteucci, et al.
Clinical Research in Cardiology (2019) Vol. 108, Iss. 7, pp. 730-740
Open Access | Times Cited: 17
Fibrosis independent atrial fibrillation in older patients is driven by substrate leukocyte infiltration: diagnostic and prognostic implications to patients undergoing cardiac surgery
Christie Aguiar, Kareem Gawdat, Stephanie Legere, et al.
Journal of Translational Medicine (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 17
Mid‐regional pro‐adrenomedullin outperforms N‐terminal pro‐B‐type natriuretic peptide for the diagnosis of acute heart failure in the presence of atrial fibrillation
Win Sen Kuan, Irwani Ibrahim, Siew Pang Chan, et al.
European Journal of Heart Failure (2019) Vol. 22, Iss. 4, pp. 692-700
Open Access | Times Cited: 16
Use of antithrombotics at the end of life: an in-depth chart review study
Bregje A.A. Huisman, Eric C.T. Geijteman, Jimmy J. Arévalo, et al.
BMC Palliative Care (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 14
Current Atrial Fibrillation Ablation: An Alert for the Prevention and Treatment of Esophageal Lesions
Maurício Scanavacca
Arquivos Brasileiros de Cardiologia (2016)
Open Access | Times Cited: 13
Physicians' Opinions on Anticoagulant Therapy in Patients with a Limited Life Expectancy
Bregje A.A. Huisman, Eric C.T. Geijteman, Nathalie Kolf, et al.
Seminars in Thrombosis and Hemostasis (2021) Vol. 47, Iss. 06, pp. 735-744
Closed Access | Times Cited: 11
Safety and efficacy of new oral anticoagulants compared to those of warfarin in AF patients with cancer: a meta-analysis of randomized clinical trials and observational studies
Yueming Chen, Min Mao, Jing Chang, et al.
European Journal of Clinical Pharmacology (2021) Vol. 77, Iss. 6, pp. 849-857
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top